Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:50:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, reflecting a minor update to the page version. It does not affect the study content.
    Difference
    0.0%
    Check dated 2026-03-12T20:31:12.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. These changes are minor and do not affect study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T00:34:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:48:29.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Introduced a glossary toggle and updated metadata labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', with the revision level updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T21:39:13.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A minor revision update was applied (from v3.3.3 to v3.3.4); no changes to study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:46:04.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.